This section considers studies on neurological, psychiatric, behavioral and developmental disorders in children and adolescents.
Page 3 of 3
In 1997 Vagus Nerve Stimulation (VNS) received approval from the US Food and Drug Administration (FDA) as an adjunctive therapy in the treatment of medically intractable partial epilepsy in people aged 12 year...
Citation: Italian Journal of Pediatrics 2010 36:30
Mental retardation is a heterogeneous condition, affecting 1-3% of general population. In the last few years, several emerging clinical entities have been described, due to the advent of newest genetic techniq...
Citation: Italian Journal of Pediatrics 2010 36:17
This epileptic disorder has become a classic topic for neuropediatricians and the interest is documented by the large number of publications on this subject.
Citation: Italian Journal of Pediatrics 2010 36:15
The aim of this study was to determine whether primary nocturnal enuresis (PNE) leads to alterations in glycosaminoglycan (GAG) excretion.
Citation: Italian Journal of Pediatrics 2010 36:13
We will discuss the clinical and genetic diagnosis of a child with severe psychomotor delay, who at 3 years of age presented with paroxysms of hyperpnea-apnea and seizures unrelated to breathing anomalies.
Citation: Italian Journal of Pediatrics 2010 36:12
A number of studies have shown that current classification systems (ICD 10, DSM IV TR) have limitation when applied to autistic children and the category PDD NOS (DSM IV TR) has in particular been criticized. ...
Citation: Italian Journal of Pediatrics 2010 36:10
Speed
68 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
136 days from submission to acceptance
19 days from acceptance to publication
Citation Impact
2.185 - 2-year Impact Factor
2.103 - 5-year Impact Factor
1.081 - Source Normalized Impact per Paper (SNIP)
0.525 - SCImago Journal Rank (SJR)
Usage
635,953 Downloads
179 Altmetric Mentions
